ContactCredit ReportFinancialsPeopleOwnershipLatest ActivityMutual CompaniesDocumentsRepayment History

Schering-Plough Clinical Trials UK Societas

Schering-Plough Clinical Trials UK Societas is a dissolved company incorporated on 22 February 2005 with the registered office located in London, Greater London. Schering-Plough Clinical Trials UK Societas was registered 20 years ago.
Status
Dissolved
Dissolved on 26 January 2022 (3 years ago)
Was 16 years old at the time of dissolution
Following liquidation
Company No
SE000001
Age
20 years
Incorporated 22 February 2005
Size
Micro
Turnover is under £1M
Balance sheet is under £500,000
Under 10 employees
Confirmation
Not Submitted
Awaiting first confirmation statement
Accounts
Not Submitted
Awaiting first accounts
Address
Ernst & Young Llp
1 More London Place
London
SE1 2AF
Same address for the past 6 years
Telephone
Unreported
Email
Unreported
Website
Unreported
People
Officers
2
Shareholders
1
Controllers (PSC)
1
British • Lives in UK • Born in Jun 1968
Company Member • Turkish • Lives in UK • Born in Oct 1972
Schering-Plough Holdings Limited
PSC
Shareholders, PSCs & Group Structure
See who truly controls a company with full PSC, Shareholder, and Group Structure exploration
Mutual Companies
Iomet Pharma Ltd
Ebru Can Temucin and Martin Ian Rogers are mutual people.
Active
Merck Sharp & Dohme (UK) Limited
Ebru Can Temucin is a mutual person.
Active
MSD R&D Innovation Centre Limited
Ebru Can Temucin is a mutual person.
Active
Schering-Plough Holdings Limited
Ebru Can Temucin is a mutual person.
Active
Merck Sharp & Dohme Finance Europe Limited
Ebru Can Temucin is a mutual person.
Active
MSD Limited
Ebru Can Temucin is a mutual person.
Active
Eyebiotech Limited
Martin Ian Rogers is a mutual person.
Active
MSD Vaccines Limited
Martin Ian Rogers is a mutual person.
Liquidation
Financials
Net Assets, Total Assets & Total Liabilities (2010–2017)
Period Ended
31 Dec 2017
For period 31 Dec31 Dec 2017
Traded for 12 months
Cash in Bank
£95.27K
Increased by £78 (0%)
Turnover
Unreported
Same as previous period
Employees
Unreported
Same as previous period
Total Assets
£95.27K
Increased by £78 (0%)
Total Liabilities
-£120
Increased by £15 (+14%)
Net Assets
£95.15K
Increased by £63 (0%)
Debt Ratio (%)
0%
Increased by 0.02% (+14%)
Latest Activity
Dissolved After Liquidation
3 Years Ago on 26 Jan 2022
Registers Moved To Inspection Address
6 Years Ago on 5 Nov 2018
Declaration of Solvency
7 Years Ago on 20 Sep 2018
Voluntary Liquidator Appointed
7 Years Ago on 20 Sep 2018
Registered Address Changed
7 Years Ago on 20 Sep 2018
Inspection Address Changed
7 Years Ago on 20 Sep 2018
Full Accounts Submitted
7 Years Ago on 12 Jul 2018
Confirmation Submitted
7 Years Ago on 25 Apr 2018
Richard Robinski Resigned
7 Years Ago on 19 Feb 2018
Louise Jane Houson Resigned
7 Years Ago on 19 Feb 2018
Get Credit Report
Discover Schering-Plough Clinical Trials UK Societas's Credit Score, how much credit you can offer them, and how likely they are to repay you
Documents
Final Gazette dissolved following liquidation
Submitted on 26 Jan 2022
Return of final meeting in a members' voluntary winding up
Submitted on 12 Jan 2021
Miscellaneous
Submitted on 6 Jan 2021
Notice of initiation or termination of winding up , liquidation, insolvency, cessation of payment procedures and decision to continue operatin
Submitted on 21 Oct 2020
Register(s) moved to registered inspection location Hertford Road Hoddesdon EN11 9BU
Submitted on 5 Nov 2018
Register inspection address has been changed to Hertford Road Hoddesdon EN11 9BU
Submitted on 20 Sep 2018
Registered office address changed from Hertford Road Hoddesdon Hertfordshire EN11 9BU to Ernst & Young Llp 1 More London Place London SE1 2AF on 20 September 2018
Submitted on 20 Sep 2018
Appointment of a voluntary liquidator
Submitted on 20 Sep 2018
Notice of initiation or termination of winding up , liquidation, insolvency, cessation of payment procedures and decision to continue operatin
Submitted on 20 Sep 2018
Resolutions
Submitted on 20 Sep 2018
Repayment History
Understand how businesses repay their debts and see how they're performing year‐on‐year